NCT04961762 is a NA clinical trial of Navigator Program in Homeless Persons, sponsored by Unity Health Toronto.

Who is sponsoring NCT04961762?

NCT04961762 is sponsored by Unity Health Toronto.

What drugs are being tested in NCT04961762?

Interventions in NCT04961762: Navigator Program.

What condition does NCT04961762 study?

NCT04961762 studies Homeless Persons, Case Management, Primary Care, Hospital Readmission.

Is NCT04961762 still recruiting?

NCT04961762 is currently active, enrolled. Last updated 1 August 2025.

Last reviewed 2025-08-01 · How we verify

NCT04961762

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Navigator Program for Homeless Adults

Active, enrolled NA Last updated 1 August 2025

What this trial tests

NA trial testing Navigator Program in Homeless Persons in 656 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline

18 October 2021

Primary endpoint
1 August 2025

1 August 2025

Quick facts

Lead sponsor	Unity Health Toronto
Phase	NA
Status	Active, enrolled
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	health services research
Enrollment	656
Start date	18 October 2021
Primary completion	1 August 2025
Estimated completion	1 August 2025
Sites	1 location across Canada

Drugs / interventions tested

Navigator Program

Conditions studied

Homeless Persons — all drugs for Homeless Persons →
Case Management — all drugs for Case Management →
Primary Care — all drugs for Primary Care →
Hospital Readmission — all drugs for Hospital Readmission →

Sponsor

Unity Health Toronto — full company profile →

Who can join

18 and older, any sex, with Homeless Persons or Case Management. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Individuals experiencing homelessness often have complex health and social needs. This population also faces disproportionate systemic barriers to accessing health care services and social supports, such as not having primary care providers, needing to meet other competing priorities, and difficulties affording medications. These barriers contribute to discontinuities in care, poor health outcomes, and high acute healthcare utilization after hospitalization among this population. This randomized controlled trial aims to evaluate the effect of a case management intervention (the Navigator program) for individuals experiencing homelessness who have been admitted to hospital for medical conditions. This study will examine outcomes over a 180-day period after hospital discharge, including follow-up with primary care providers, acute healthcare utilization, quality of care transitions, and overall health.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Navigator programme for hospitalised adults experiencing homelessness: protocol for a pragmatic randomised controlled trial.
Liu M, Pridham KF, Jenkinson J, Nisenbaum R, et al · · 2022 · cited 6× · PMID 36517099 · DOI 10.1136/bmjopen-2022-065688

Verify or expand the search:

Other recruiting trials for Homeless Persons

Currently open trials in the same condition.

NCT06723093 — Evaluation of a Supportive Housing Program for Adults Who Are Unhoused and Have Complex Health Needs · NA · recruiting

Other Unity Health Toronto trials

Trials by the same sponsor.

NCT07507409 — Innovative Sternal Closure Techniques: Evaluating STRATAFIX™ and DERMABOND™ for Reduced Complications in CABG Patients · Phase 4 · not yet recruiting
NCT07455487 — First Appendectomy Using Revolve Surgical Robotic Arm · NA · not yet recruiting
NCT07301632 — Ecstasy to Alleviate SEvere Chronic Neuropathic Pain Trial · Phase 2 · recruiting
NCT07314905 — Adaptive Platform Trial of Treatments for Respiratory Infections in Community Settings (TreatResp) · Phase 3 · not yet recruiting
NCT06571916 — Brief Skills for Safer Living (Brief-SfSL) · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04961762 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Unity Health Toronto
Last refreshed: 1 August 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04961762.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing